➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
AstraZeneca
Baxter
Johnson and Johnson
Express Scripts

Last Updated: June 4, 2020

DrugPatentWatch Database Preview

Cefazolin sodium - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for cefazolin sodium and what is the scope of freedom to operate?

Cefazolin sodium is the generic ingredient in eight branded drugs marketed by Glaxosmithkline, Baxter Hlthcare, B Braun, Abraxis Pharm, Acs Dobfar, Aurobindo Pharma, Bedford, Cephazone Pharma, Dr Reddys, Facta Farma, Fresenius Kabi Usa, Hikma Farmaceutica, Hospira Inc, Qilu, Samson Medcl, Sandoz, Steri Pharma, Teva Pharms, West-ward Pharms Int, Lilly, and Baxter Hlthcare Corp, and is included in thirty-nine NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for cefazolin sodium. Fifteen suppliers are listed for this compound.

Recent Clinical Trials for cefazolin sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of British ColumbiaEarly Phase 1
Aswan University HospitalN/A
Federal University of São PauloPhase 4

See all cefazolin sodium clinical trials

Pharmacology for cefazolin sodium
Medical Subject Heading (MeSH) Categories for cefazolin sodium
Synonyms for cefazolin sodium
27164-46-1
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-, (6R-trans)-, sodium salt
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-, monosodium salt (6R-trans)-
AC-13166
AKOS015895533
Ancef
Ancef (TN)
ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER
ANCEF IN PLASTIC CONTAINER
ANCEF IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
AS-12230
Atirin
BDBM50247885
Biazolina
Bor-Cefazol
C 5020
C-44235
C08098
C14H13N8NaO4S3
CCG-40011
Cefabiozim
Cefacidal
Cefalomicina
Cefamedin
Cefazil
Cefazina
Cefazolin (sodium)
CEFAZOLIN AND DEXTROSE
Cefazolin sodium (JP17/USP)
Cefazolin sodium [USAN:USP:JAN]
Cefazolin sodium salt
Cefazolin sodium salt, 89.1-110.1%
Cefazolin sodium salt, Antibiotic for Culture Media Use Only
cefazolin-sodium
Cefazoline sodium
Cephazolin Sodium
CEZ sodium
CHEBI:3483
CHEMBL1200523
CS-4634
D00905
EINECS 248-278-4
EU-0100274
Firmacef
FLKYBGKDCCEQQM-WYUVZMMLSA-M
Gramaxin
HMS1570C14
HMS1920K07
HMS2091A10
HMS2097C14
HMS2230I22
HMS3260H10
HMS3714C14
HMS500A16
HY-B1078
Kefzol
KS-00000FVS
Lampocef
Lilly 46083
Liviclina
LP00274
MCULE-2075772357
MFCD00056883
MLS000028706
Monosodium (6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
Monosodium cefazolin
NCGC00093731-01
NCGC00260959-01
Neofazol
NSC 291561
NSC-291561
Opera_ID_1323
P380M0454Z
Prestwick_975
Q27106104
Recef
s4595
SCHEMBL40735
SK&F-41558
SKF 41558
SMR000058708
Sodium (6R-trans)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(1H-tetrazol-1-ylacetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
Sodium (6R,7R)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
sodium (6R,7R)-3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-8-oxo-7-[(1H-tetrazol-1-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium (6R,7R)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-((5-methyl-1,3,4-thiadiazol-2-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
sodium 3-{[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]methyl}-7beta-[(1H-tetrazol-1-ylacetyl)amino]-3,4-didehydrocepham-4-carboxylate
sodium 7beta-(1H-tetrazol-1-yl)acetamido-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate
sodium 7beta-[2-(1H-tetrazol-1-yl)-acetamido]-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate
sodium 7beta-[2-(1H-tetrazol-1-yl)acetamido]-3-(2-methyl-1,3,4-thiadiazol-5-yl)thiomethyl-3-cephem-4-carboxylate
Sodium cefazolin
Sodium cephazolin
Sodium CEZ
Sodium CEZ; SKF-41558
sodium;(6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-8-oxo-7-[[2-(tetrazol-1-yl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
SPECTRUM1500164
ST024775
Totacef
Tox21_500274
UNII-P380M0454Z
Zolicef
Zolin
Zolisint
ZX-AFC000519

US Patents and Regulatory Information for cefazolin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare ANCEF IN PLASTIC CONTAINER cefazolin sodium INJECTABLE;INJECTION 063002-001 Mar 28, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 062831-001 Dec 9, 1988 AP RX No No   Start Trial   Start Trial   Start Trial
Hikma Farmaceutica CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 065047-001 Sep 18, 2001 AP RX No Yes   Start Trial   Start Trial   Start Trial
Baxter Hlthcare ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER cefazolin sodium INJECTABLE;INJECTION 050566-004 Jun 8, 1983 DISCN Yes No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 064170-002 Mar 18, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Acs Dobfar KEFZOL cefazolin sodium INJECTABLE;INJECTION 061773-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare ANCEF IN DEXTROSE 5% IN PLASTIC CONTAINER cefazolin sodium INJECTABLE;INJECTION 050566-003 Jun 8, 1983 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
AstraZeneca
Baxter
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.